CFTR and cystic fibrosis: The in vitro studies employed TNFα and IL-17 as inflammatory stimuli [60], and their findings are in agreement with our previous in vitro studies demonstrating that the CF airway inflammatory milieu enhances the efficacy of CFTR modulators [32,58].